
Cannabis, Hemp & CBD Securities Compliance
Cannabis companies that file with the SEC face a legal paradox unique in American securities law: they must provide full and accurate disclosure about business operations that remain federally illegal under the Controlled Substances Act, regardless of state-level legalization, voter referenda, or evolving public policy sentiment. This is not a theoretical concern. It is the defining characteristic of cannabis securities disclosure, and it creates risk factor obligations, revenue recognition questions, banking limitation disclosures, going concern considerations, and potential criminal exposure disclosures that have no parallel in any other industry.
The SEC expects cannabis issuers to disclose the specific federal laws they are violating, the potential consequences of federal enforcement action, the limitations on banking services and capital access created by federal illegality, the impact of IRC Section 280E on their effective tax rate and cash flow, the risk of federal forfeiture of assets used in connection with controlled substance activities, and the potential impact on the company's ability to continue as a going concern if federal enforcement policy changes. Inadequate disclosure in any of these areas creates enforcement risk that compounds with every subsequent filing.
Frederick M. Lehrer has experience advising cannabis, hemp, and CBD issuers on the precise disclosure language required to satisfy these obligations while providing investors with the accurate, complete picture of regulatory risk that federal securities law demands.




